Cargando…
Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma
BACKGROUND: Treatment of renal cancer has significantly improved with the arrival to the clinic of kinase inhibitors and immunotherapies. However, the disease is still incurable in advanced stages. The fact that several approved inhibitors for kidney cancer target receptor tyrosine kinases (RTKs) su...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365933/ https://www.ncbi.nlm.nih.gov/pubmed/34399807 http://dx.doi.org/10.1186/s13046-021-02051-0 |